Search…

Fangsheng Pharmaceutical: Net profit in the first half of 2025 increased by 23.67% year-on-year.

29/08/2025

Fangsheng Pharmaceutical announced that the operating income in the first half of 2025 was 834 million yuan, a year-on-year decrease of 8.35%. The net profit was 169 million yuan, a year-on-year growth of 23.67%. The company plans to distribute a cash dividend of 1.5 yuan per 10 shares to all shareholders.

Latest

2 m ago

Deko (688205.SH) released its semi-annual performance report, with a net profit attributable to the parent company of 28.09 million yuan, a year-on-year decrease of 48.17%.

2 m ago

On Thursday, the South Korean won finally rose by 0.67% against the US dollar, closing at 1384.37 won, with continual fluctuation in an upward direction throughout the day.

3 m ago

The White House: We will continue to struggle with the Fed Chairman Cook.

4 m ago

Japan Steel Corporation stated that the acquisition of American steel company X.N brought them one step closer to achieving their long-term goal of producing 100 million tons of crude steel annually. Vice President of Japan Steel Corporation, Takahiro Mori, also mentioned that the profit contribution from X.N would help the company get closer to their target of 1 trillion yen in operating profit.

6 m ago

Tonglian Precision (688210.SH) released its performance for the first half of the year, with a net profit attributable to the parent company of 4.8731 million yuan, a decrease of 88.24%

See all latest